A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
NATURAL HEALTH TRENDS CORP
NHTC
$20M
Mkt Cap
$1.80
+0.00%
NATURAL HEALTH TRENDS CORP (NHTC) has a 5-year average return on invested capital (ROIC) of 0.4%. This is below average and may indicate limited pricing power.
NATURAL HEALTH TRENDS CORP (NHTC) has a market capitalization of $23M. It is classified as a small-cap stock.
Yes, NATURAL HEALTH TRENDS CORP (NHTC) pays a dividend with a trailing twelve-month yield of 33.24%.
NATURAL HEALTH TRENDS CORP (NHTC) operates in the Wholesale-Miscellaneous Nondurable Goods industry, within the Consumer Defensive sector.
NATURAL HEALTH TRENDS CORP (NHTC) reported annual revenue of $40 million in its most recent fiscal year, based on SEC EDGAR filings.
NATURAL HEALTH TRENDS CORP (NHTC) has a net profit margin of -2.2%. The company is currently unprofitable.
NATURAL HEALTH TRENDS CORP (NHTC) generated $-6 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Overview of Business Natural Health Trends Corp. is an international direct-selling and e-commerce company. Through our subsidiaries, we sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. Our wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico, Peru and Colombia; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Malaysia and Singapore; South Korea; Japan; India; and Europe. We also operate in Russia and Kazakhstan through our engagement with a local service provider. Most of our order volume, particularly in our Hong Kong subsidiary, is for personal consumption through existing members’ referrals. Our objectives are to enrich the lives of our customers and enable our members to benefit financially from the sale of our products.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 38M | 40M | 43M | 44M | 49M | 60M |
| Net Income | -1.2M | -882K | 572K | 568K | 313K | 1.1M |
| EPS | $-0.09 | $-0.08 | $0.05 | $0.05 | $0.03 | $0.09 |
| Free Cash Flow | -7.4M | -6.1M | -3.4M | -4.3M | -5.0M | 791K |
| ROIC | -4.8% | -3.1% | 1.5% | 1.4% | 0.6% | 1.8% |
| Gross Margin | 73.9% | 73.5% | 74.0% | 74.6% | 74.2% | 75.0% |
| Debt/Equity | 0.00 | 0.09 | 0.08 | 0.66 | 0.08 | 0.05 |
| Dividends/Share | $0.60 | $0.80 | $0.80 | $0.81 | $0.80 | $0.80 |
| Operating Income | -1.9M | -1.8M | -1.3M | -1.7M | -270K | 1.6M |
| Operating Margin | -5.1% | -4.5% | -3.0% | -3.8% | -0.5% | 2.6% |
| ROE | -7.0% | -3.1% | 1.5% | 1.4% | 0.6% | 1.7% |
| Shares Outstanding | 13M | 11M | 11M | 11M | 10M | 12M |
| Metric | 2014 | 2015 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 125M | 265M | 288M | 198M | 192M | 78M | 62M | 60M | 49M | 44M | 43M | 40M | 38M |
| Gross Margin | 78.3% | 79.6% | 80.9% | 38.6% | 79.5% | 74.1% | 72.6% | 75.0% | 74.2% | 74.6% | 74.0% | 73.5% | 73.9% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 20M | 36M | 43M | 32M | 31M | 27M | 18M | 18M | 16M | 16M | 16M | 15M | 15M |
| EBIT | 21M | 48M | 64M | 43M | 34M | -7.0M | 669K | 1.6M | -270K | -1.7M | -1.3M | -1.8M | -1.9M |
| Op. Margin | 16.7% | 18.1% | 22.3% | 21.8% | 17.6% | -9.0% | 1.1% | 2.6% | -0.5% | -3.8% | -3.0% | -4.5% | -5.1% |
| Net Income | 20M | 47M | 55M | 24M | 31M | -5.6M | 843K | 1.1M | 313K | 568K | 572K | -882K | -1.2M |
| Net Margin | 16.3% | 17.8% | 19.1% | 11.9% | 16.2% | -7.2% | 1.4% | 1.8% | 0.6% | 1.3% | 1.3% | -2.2% | -3.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 77.7% | 83.3% | 79.2% | 29.9% | 33.6% | -6.8% | 0.6% | 1.8% | 0.6% | 1.4% | 1.5% | -3.1% | -4.8% |
| ROE | 125.2% | 113.5% | 79.1% | 27.2% | 34.4% | -6.8% | 1.2% | 1.7% | 0.6% | 1.4% | 1.5% | -3.1% | -7.0% |
| ROA | 56.3% | 53.5% | 40.5% | 15.3% | 19.6% | -4.1% | 0.8% | 1.1% | 0.3% | 0.8% | 0.9% | -1.9% | -3.6% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 31M | 81M | 53M | 27M | 30M | -19M | 1.9M | 1.0M | -4.9M | -4.3M | -3.4M | -6.0M | -7.3M |
| Free Cash Flow | 30M | 81M | 52M | 26M | 29M | -19M | 1.7M | 791K | -5.0M | -4.3M | -3.4M | -6.1M | -7.4M |
| Owner Earnings | 30M | 81M | 53M | 26M | 29M | -20M | 965K | 547K | -5.1M | -4.6M | -3.6M | -6.2M | -7.5M |
| CapEx | 339K | 710K | 905K | 278K | 214K | 189K | 211K | 225K | 143K | 46K | 57K | 68K | 167K |
| Maint. CapEx | 105K | 263K | 394K | 536K | 424K | 387K | 410K | 299K | 204K | 164K | 131K | 109K | 90K |
| Growth CapEx | 234K | 447K | 511K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77K |
| D&A | 105K | 263K | 394K | 536K | 424K | 387K | 410K | 299K | 204K | 164K | 131K | 109K | 90K |
| CapEx/OCF | 1.1% | 0.9% | 1.7% | 1.0% | 0.7% | N/A | 11.2% | 22.1% | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 476K | 1.7M | 6.9M | 17M | 32M | 7.3M | 9.1M | 9.1M | 9.1M | 9.2M | 9.2M | 9.2M | 7.8M |
| Dividend Yield | 1.4% | 1.5% | 6.3% | 18.3% | 34.3% | 16.8% | 31.3% | 20.7% | 26.2% | 22.4% | 16.4% | 21.1% | 33.2% |
| Share Buybacks | 4.7M | 16M | 24M | 0 | 0 | 10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 10.1% | 10.0% | 23.5% | N/A | N/A | 39.9% | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 49K | 86K | 104K | 35K | 0 | 925K | 510K | 170K | 0 | 161K | 145K | 132K | 98K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | N/A | -175M | -157M | -147M | -122M | N/A | -41M | -27M | -21M |
| Cash & Equiv. | 45M | 105M | 126M | 135M | 133M | 96M | 92M | 84M | 70M | 56M | 14M | 6.8M | 21M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.99 | 1.19 | 0.80 | 0.76 | 0.76 | 0.04 | 0.06 | 0.05 | 0.08 | 0.66 | 0.08 | 0.09 | 0.00 |
| Interest Coverage | 20820.0 | N/A | 7126.2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 26M | 57M | 82M | 91M | 90M | 75M | 68M | 59M | 50M | 42M | 33M | 23M | 16M |
| Total Assets | 53M | 124M | 148M | 160M | 158M | 118M | 106M | 98M | 83M | 69M | 55M | 38M | 32M |
| Total Liabilities | 26M | 67M | 66M | 69M | 68M | 43M | 38M | 39M | 33M | 27M | 22M | 15M | 15M |
| Intangibles | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -55M | -9.6M | 39M | 45M | 44M | 16M | 7.8M | -231K | -9.1M | -18M | -26M | -36M | -37M |
| Working Capital | 25M | 56M | 84M | 109M | 107M | 82M | 78M | 69M | 57M | 44M | 30M | 21M | 13M |
| Current Assets | 50M | 118M | 141M | 151M | 150M | 108M | 100M | 93M | 78M | 64M | 51M | 34M | 27M |
| Current Liabilities | 24M | 62M | 57M | 42M | 43M | 26M | 22M | 25M | 20M | 20M | 21M | 14M | 13M |
| Per Share Data | |||||||||||||
| EPS | 1.61 | 3.82 | 4.83 | 2.09 | 2.74 | -0.52 | 0.07 | 0.09 | 0.03 | 0.05 | 0.05 | -0.08 | -0.09 |
| Owner EPS | 2.41 | 6.55 | 4.62 | 2.31 | 2.59 | -1.85 | 0.08 | 0.05 | -0.48 | -0.41 | -0.32 | -0.57 | -0.58 |
| Book Value | 2.09 | 4.59 | 7.23 | 8.03 | 7.93 | 6.96 | 5.62 | 4.93 | 4.81 | 3.66 | 2.87 | 2.13 | 1.27 |
| Cash Flow/Share | 2.42 | 6.58 | 4.66 | 2.36 | 2.62 | -1.73 | 0.16 | 0.08 | -0.47 | -0.38 | -0.29 | -0.54 | -0.08 |
| Dividends/Share | 0.03 | 0.14 | 0.61 | 1.52 | 2.77 | 0.64 | 0.80 | 0.80 | 0.80 | 0.81 | 0.80 | 0.80 | 0.60 |
| Shares Out. | 12.6M | 12.4M | 11.4M | 11.3M | 11.3M | 10.8M | 12.0M | 12.1M | 10.4M | 11.4M | 11.4M | 11.0M | 13.0M |
| Valuation | |||||||||||||
| P/E Ratio | 2.3 | 3.4 | 1.8 | 2.7 | 2.8 | N/A | 36.2 | 41.7 | 74.1 | 84.8 | 73.5 | N/A | -19.2 |
| P/FCF | 1.5 | 2.0 | 1.9 | 2.4 | 2.9 | N/A | 18.2 | 57.2 | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 1.7 | 2.8 | 1.2 | 0.7 | 1.0 | 0.3 | 0.5 | 0.8 | 0.5 | 1.2 | 1.3 | 1.5 | 1.4 |
| Price/Sales | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.7 | 0.7 | 0.9 | 1.3 | 1.1 | 0.6 |
| FCF Yield | 65.4% | 50.3% | 51.7% | 41.2% | 34.1% | -74.3% | 5.5% | 1.7% | -21.5% | -9.0% | -8.1% | -17.0% | -31.9% |
| Market Cap | 46M | 160M | 101M | 64M | 86M | 25M | 31M | 45M | 23M | 48M | 42M | 36M | 23M |
| Avg. Price | 2.66 | 9.52 | 9.53 | 8.34 | 8.12 | 4.04 | 2.42 | 3.66 | 3.34 | 3.62 | 4.90 | 3.97 | 1.80 |
| Year-End Price | 3.66 | 12.95 | 8.86 | 5.66 | 7.63 | 2.35 | 2.53 | 3.75 | 2.22 | 4.24 | 3.68 | 3.23 | 1.80 |
NATURAL HEALTH TRENDS CORP passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 0.4% with a gross margin of 74.3%. Total shareholder yield (dividends) is 33.2%. At current prices, the estimated annualized return to fair value is -51.3%.
NATURAL HEALTH TRENDS CORP (NHTC) has a debt-to-equity ratio of 0.09. This indicates a conservatively financed balance sheet.
NATURAL HEALTH TRENDS CORP (NHTC) reported earnings per share (EPS) of $-0.08 in its most recent fiscal year.
NATURAL HEALTH TRENDS CORP (NHTC) has a return on equity (ROE) of -3.1%. A negative ROE may indicate losses or negative equity.
NATURAL HEALTH TRENDS CORP (NHTC) has a 5-year average gross margin of 74.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for NATURAL HEALTH TRENDS CORP (NHTC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NATURAL HEALTH TRENDS CORP (NHTC) has a book value per share of $2.13, based on its most recent annual SEC filing.